| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.0M | — | +26.8% |
| R&D Expense | $4.0M | — | -75.7% |
| SG&A Expense | $8.6M | — | -45.4% |
| Operating Income | -$9.8M | — | +68.4% |
| Income Tax | $0 | — | — |
| Net Income | -$14.7M | — | +23.7% |
| EPS (Basic) | -$1.77 | — | -1670.0% |
| EPS (Diluted) | -$1.77 | — | -1670.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $19.9M | +50.9% | +44.2% |
| Accounts Receivable | $10.6M | +10.8% | +16.5% |
| Current Assets | $48.0M | +20.8% | -16.8% |
| Total Assets | $105.2M | +5.0% | -16.4% |
| Current Liabilities | $24.4M | -11.9% | -7.9% |
| Total Liabilities | $57.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.3M | — | +56.1% |
| Capital Expenditures | $55K | — | -92.3% |
| Investing Cash Flow | -$2.0M | — | -147.0% |
| Financing Cash Flow | $18.0M | — | +244.0% |
| Free Cash Flow | -$9.3M | — | +57.3% |
| -55.0% |
| Stockholders' Equity | $48.1M | +1334.8% | +4193.6% |